B3GALT5 and colonic neoplasm: EdU incorporation assays further displayed that enhanced expression of B3GALT5-AS1 markedly suppressed cell proliferation, and while B3GALT5-AS1 knockdown markedly promoted proliferation of colon cancer cells (Fig. 2E, F).